CalSTRS Allocates $200M to Kennedy Lewis for Credit Investments

The pension behemoth will invest assets in secured lending with the debt-oriented asset manager.



Alternative investment manager Kennedy Lewis Investment Management announced it has entered into a partnership with the California State Teachers’ Retirement System, with the pension fund providing $200 million of seed capital to Kennedy Lewis. 

The partnership, announced Tuesday, will focus on senior corporate lending for non-sponsored borrowers. The alternatives manger specializes in credit investments such as direct lending, opportunistic credit, homebuilder finance, core lending and broadly syndicated loan strategies, according to the announcement.

New York-based Kennedy Lewis is active in collateralized loan obligations, homebuilder finance and syndicated loans, and it manages a business development company.

In March, CalSTRS staff finalized a plan to increase the fund’s allocation to its fixed-income portfolio by 2%, specifically to private credit with a focus on direct lending. More broadly, in May 2023, the pension giant announced a new asset allocation plan featuring a 4% reduction in equities and the 2% fixed-income boost, plus a 1% increase to private equity and inflation-sensitive assets, respectively. 

Want the latest institutional investment industry
news and insights? Sign up for CIO newsletters.

In May 2024, the CalSTRS board approved a further 1% increase in the allocation to fixed income, effective in July, with the bulk of the increase going to direct lending. As a part of a long-term strategic asset allocation plan, CalSTRS increased its fixed-income target weight from 12% to 13% to support an increase in allocation to direct lending, funding the move with a further 1% reduction in its exposure to equities.

As of December 31, 2023, the total assets under management for CalSTRS’ private credit investments was approximately $7.5 billion. 

“There is currently an extremely compelling opportunity set that is complementary to sponsor-backed lending mandates within the non-sponsored direct lending space,” said David Chene and Darren Richman, co-founders and co-managing partners of Kennedy Lewis, in a statement. “We see the potential to achieve diversification across industries and secure beneficial terms and pricing.”

CalSTRS manages $337.9 billion in assets for more than 1 million beneficiaries. Kennedy Lewis, founded in 2017, manages $16 billion across its business units.


Related Stories:

CalSTRS Focuses on Curbing Methane in 2024 Proxy Season

CalSTRS, HESTA Invest in Generate Capital’s Sustainable Infrastructure Platform

CalSTRS Board Approves Plan to Increase Portfolio Leverage up to 10%


Tags: , , , ,

Atlanta Pension Settles Price-Fixing Lawsuit Against Taro Pharmaceuticals

Sun Pharma-owned pharmaceutical company agrees to pay $36 million due to allegations it fixed prices and misled investors.



A group of investors led by the City of Atlanta Firefighters’ Pension Fund has agreed to a $36 million
settlement related to a securities fraud class action claim against Taro Pharmaceuticals Industries Ltd. 

The investor group sued Taro Pharmaceuticals in June 2017, alleging the company violated federal securities laws by issuing materially false and misleading statements and made omissions related to its competition and the cause of its sales growth. It also accused Taro of fixing prices on at least seven drugs with other generic drug companies and hiding this information from investors.  

According to court documents, Taro “reaped over $1.5 billion in collusive revenue from this alleged price fixing” between mid-2013 and 2016, which accounted for 47% of the company’s revenues during this time.  

“This conspiracy was possible because the markets for the drugs were highly susceptible to collusion, specifically because they were dominated by only a few companies,” the investors wrote in their complaint.  

For more stories like this, sign up for the CIO Alert newsletter.

If approved by the court, the settlement will create a $36 million cash fund, plus earned interest, for eligible class members, before the deduction of attorneys’ fees and expenses. According to the Atlanta Firefighters’ damages expert, the amount is equal to an average recovery of approximately $2.53 per allegedly damaged share, before deductions.  

Lawyers for the investors said they decided to settle the case due to the “expense and length” of the legal proceedings needed to pursue the claims through trial and appeals, as well as the difficulties in establishing liability.  

According to the settlement, approved in May by U.S. District Judge Andrew L. Carter Jr. in U.S. District Court for the Southern District of New York, Taro continues to deny “each and every one of the claims” alleged by the investors and agreed to settle the claims “to avoid and eliminate the burden, expense, uncertainty, and risk of further litigation.” The settlement stipulates that it is not an admission of any wrongdoing by Taro or its employees. 

Representatives from Taro Pharmaceuticals could not be reached for comment. Its parent company, Sun Pharmaceutical Industries Ltd., did not immediately respond to a request for comment.  


Related Stories:

Largest Class Action Settlements of 2023

Aon Agrees to $1.5M Settlement With SEC Over Pennsylvania Pension Data

Ryanair Settles Lawsuit With Alabama Pension Fund


Tags: , , , , , ,

«

PW Pro Content

PW Pro users get immediate unlimited access to all content.